(EYE oh BEN gwayne) Brand: AdreView
• You must not receive this medicine if you are allergic to iobenguane. Speak your doctor if you have ever had any type of reaction to other contrast agent, or to potassium.
• Till you are treated with iobenguane I-123, speak your doctor if you have kidney malady, a thyroid mess, if you are dehydrated or unable to urinate, or if you are allergic to iodine.
• Speak your doctor about all another medications you are using, especially antidepressants, cool medicines, blood pressure medications, or ADHD medications. You may need to stop using determined drugs for a short time till you receive iobenguane I-123
• Drink extra fluids till you receive iobenguane I-123, and for at least 48 hours afterward. Follow your doctor's instructions about the types and amount of liquids you must drink till and after your test. Iobenguane I-123 is radioactive and it can reason dangerous effects on your bladder if it is not properly eliminated from your body through urination.
• Do not let yourself to become dehydrated during the first little days after receiving iobenguane I-123. Call your doctor if you have any vomiting or diarrhea during this time. Follow your doctor's instructions about the types and amount of fluids you must drink.
• Iobenguane I-123 is in a group of drugs called diagnostic radiopharmaceuticals (RAY dee oh far ma SOO tik als). Iobenguane I-123 is a radioactive agent that allows images of specific organs in the body to be detected by a gamma camera.
• Iobenguane I-123 is used to discover determined kinds of cancer of the adrenal glands
• Iobenguane I-123 may also be used for purposes not listed in this medicine guide.
• You must not receive this medicine if you are allergic to iobenguane. Speak your doctor if you have ever had any type of reaction to other contrast agent, or to potassium.
• To create certain you can safely receive iobenguane I-123, speak your doctor if you have any of these another conditions:
· kidney disease;
· a thyroid disorder;
· if you are dehydrated or unable to urinate; or
· if you are allergic to iodine.
• FDA pregnancy category C. It is not known whether iobenguane I-123 will harm an unborn child. Speak your doctor if you are pregnant till you are treated with iobenguane I-123.
• It is not known whether iobenguane I-123 passes into breast milk or if it could harm a nursing child. Do not breast-feed within 6 days after receiving iobenguane I-123. If you use a breast exhaust during this time, throw out any milk you collect. Do not feed it to your baby.
• Older adults may need kidney function trials till receiving iobenguane I-123. Your kidney function may also need to be watched closely after you have received this medication.
• Iobenguane I-123 is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. It is generally given about 24 hours till your radiologic test.
• At least 1 hour till you are treated with iobenguane I-123, you will be given a liquid drink that contains medication to protect your thyroid from deleterious radioactive effects of iobenguane I-123.
• Drink extra fluids till you receive iobenguane I-123, and for at least 48 hours afterward. Follow your doctor's instructions about the types and amount of liquids you must drink till and after your test. Iobenguane I-123 is radioactive and it can reason dangerous effects on your bladder if it is not properly eliminated from your body through urination.
• Suppose to urinate often during the first 48 hours after your test. You will know you are getting satis extra fluid if you are urinating more than normal during this time. Urinating often will help rid your body of the radioactive iodine.
• Since iobenguane I-123 is used only given once till your radiologic test, you will not be on a daily dosing schedule. Call your doctor if for some cause you will not be able to complete your radiologic test within 24 hours after you receive your injection.
• Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
• Do not let yourself to become dehydrated during the first little days after receiving iobenguane I-123. Call your doctor if you have any vomiting or diarrhea during this time. Follow your doctor's instructions about the types and amount of fluids you must drink.
• Get abnormal medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your person, lips, tongue, or throat.
• Smaller serious side effects may include:
· dizziness;
· mild skin rash or itching;
· bleeding near your IV needle; or
· warmth, tingling, or cool feeling where the medication was injected.
• This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may message side effects to FDA at 1-800-FDA-1088.
• You may need to stop using determined drugs for a short time till you receive iobenguane I-123. Speak your doctor about all another medications you are using, especially:
· atomoxetine (Strattera);
· labetalol (Normodyne, Trandate);
· maprotiline (Ludiomil);
· reserpine;
· decongestant cool medicines, diet pills, and another stimulants;
· an antidepressant such as amitriptyline (Elavil, Vanatrip, Limbitrol), amoxapine (Asendin), bupropion (Wellbutrin, Zyban), citalopram (Celexa), desipramine (Norpramin), doxepin (Sinequan), fluoxetine (Prozac, Sarafem, Symbyax), fluvoxamine (Luvox), imipramine (Tofranil), nortriptyline (Pamelor), paroxetine (Paxil), sertraline (Zoloft), and others; or
· street drugs, especially cocaine.
• There may be another drugs that can affect iobenguane I-123. Speak your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal commodity, and drugs predesigned by another doctors. Do not start using a new medicine without telling your doctor.
• Your doctor or pharmacist can provide more information about iobenguane I-123.
Remember, hold this and all another medicines out of the reach of children, never share your medicines with others, and use this medicine only for the indication prescribed.
Disclaim: Each effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses external of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way must be construed to indicate that the drug or drug combination is safety, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the help of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.